Publication | Closed Access
3-Methoxytyramine: An independent prognostic biomarker that associates with high-risk disease and poor clinical outcome in neuroblastoma patients
22
Citations
28
References
2017
Year
Neuroblastoma PatientsMedicinePoor Clinical OutcomeNeurologyHigh-grade GliomasIndependent Prognostic BiomarkerOncologyRadiation OncologyCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1